Longitudinal models for AIDS marker data

Statistical Methods in Medical Research

Volumn 7, Issue 1, 1998, Pages 13-27

  Boscardin, W John ^a   Taylor, Jeremy M G ^a   Law, Ngayee ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COVARIANCE; DISEASE COURSE; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; RANDOMIZATION; REVIEW; STOCHASTIC MODEL; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; DATA INTERPRETATION, STATISTICAL; HIV; HUMANS; LONGITUDINAL STUDIES; MODELS, BIOLOGICAL; MODELS, STATISTICAL; RNA, VIRAL; STOCHASTIC PROCESSES;

EID: 0031780363     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/096228098674392113     Document Type: Review

References (39)

1. Hughes MD, Stein DS, Gundacker HM et al. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. The Journal of Infectious Diseases 1994; 169: 28-36.
2. Zeger SL, Diggle PJ. Semiparametric models for longitudinal data with application to CD4 cell numbers in HIV seroconverters. Biometrics 1994; 50: 689-99.
3. Cowles MK. Bayesian accelerated failure time models for surrogate markers and survival time. Proceedings of the section on Bayesian statistical science. Alexandria, VA: American Statistical Association, 1996; 158-61.
4. Raboud JM, Montaner JSG, Conway B et al. Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus. Journal of Infectious Diseases 1996; 174: 191-94.
5. Paxton WB, Coombs RW, McElrath MJ et al. Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-infected subjects with >400 CD4 lymphocytes: Implications for applying measurements to individual patients. The Journal of Infectious Diseases 1997; 175: 247-54.
6. Jewell N, Nielsen JP. A framework for consistent prediction rules based on markers. Biometrika 1993; 80: 153-64.
7. Jewell NP, Kalbfleisch JD. Marker processes in survival analysis. In: Jewell N, Dietz K, Farewell V eds. AIDS epidemiology: methodological issues, Boston, MA: Birkhäuser, 1992: 211-30.
8. Fusaro RE, Nielsen JP, Scheike TH. Marker-dependent hazard estimation: an application to AIDS. Statistics in Medicine 1993; 12: 843-65.
9. Taylor JMG, Cumberland WG, Sy JP. A stochastic model for analysis of longitudinal AIDS data. Journal of the American Statistical Association 1994; 89: 727-36.
10. Laird NM, Ware JH. Random effects models for longitudinal data. Biometrics 1982; 38: 963-974.
11. Muñoz A, Cary V, Saah AJ et al. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. Journal of the Acquired Immune Deficiency Syndrome 1988; 1: 396-404.
12. DeGruttola V, Lange N, Dafni U. Modeling the progression of HIV infection. Journal of the American Statistical Association 1991; 86: 569-77.
13. Lange N, Carlin BP, Gelfand AE. Hierarchical Bayes models for the progression of HIV infection using longitudinal CD4 T-cell numbers. Journal of the American Statistical Association 1992; 87: 615-32.
14. Carlin BP. Hierarchical longitudinal modeling. In: Gilks W, Richardson S, Spiegelhalther D eds. Markov Chain Monte Carlo in practice. London: Chapman & Hall, 1996: 303-19.
15. Kiuchi AS, Hartigan JA, Holford T, Rubinstein P, Stevens CE. Change points in the series of T4 counts prior to AIDS. Biometrics 1995; 51: 236-48.
16. Shi M, Weiss RE, Taylor JMG. An analysis of paediatric CD4 counts for acquired immune deficiency syndrome using flexible random curves. Applied Statistics 1996; 45: 151-63.
17. Bacchetti P, Moss AR. Incubation period of AIDS in San Francisco. Nature 1989; 338: 251-53.
18. Diggle PJ. An approach to the analysis of repeated measurements. Biometrics 1988; 44: 959-71.
19. Berman SM. A stochastic model for the distribution of HIV latency time based on T4 counts. Biometrika 1990; 77: 733-41.
20. Kanazawa Y. Estimating expected time of infection with HIV. Technical report 13, SIMS (Statistical Methodology for study of the AIDS Epidemic), 1990.
21. Galai N, Muñoz A, Chen K et al. Tracking of markers and onset of disease among HIV-1 seroconverters. Statistics in Medicine 1993; 12: 2133-45.
22. Vittinghoff E, Malani HM, Jewell NP. Estimating patterns of CD4 lymphocyte decline using data from a prevalent cohort of HIV infected individuals. Statistics in Medicine 1994; 13: 1101-18.
23. Wang Y, Taylor JMG. Inference for smooth curves in longitudinal data with application to an AIDS clinical trial. Statistics in Medicine 1995; 14: 1205-18.
24. Taylor JMG, Law N. Does the covariance structure matter in longitudinal modelling for the prediction of future CD4 counts? Statistics in Medicine 1998 (in press).
25. LaValley MP, DeGruttola V. Models for empirical Bayes estimators of longitudinal CD4 counts. Statistics in Medicine 1996; 15: 2289-305.
26. Silverman BW. Spline smoothing: the equivalent variable kernel method. Annals of Statistics 1984; 12: 898-916.
27. Tsiatis AA, DeGruttola V, Wulfsohn MS. Modeling the relationship of survival to longitudinal data measured with error, applications to survival and CD4 counts in patients with AIDS. Journal of the American Statistical Association 1995; 90: 27-37.
28. Sy JP, Taylor JMG, Cumberland WG. A stochastic model for the analysis of bivariate longitudinal AIDS data. Biometrics 1997; 53: 542-55.
29. Jones RH. Longitudinal data with serial correlation: a state-space approach. London: Chapman & Hall, 1993.
30. Cox DR, Miller HD. The theory of stochastic processes. New York: John Wiley, 1965.
31. DeGruttola V, Tu XM. Modelling progression of CD4-lymphocyte count and its relationship to survival time. Biometrics 1994; 50: 1003-14.
32. Faucett CL, Thomas DC. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. Statistics in Medicine 1996; 15: 1663-85.
33. Pawitan Y, Self S. Modeling disease marker processes in AIDS. Journal of the American Statistical Association 1993; 88: 719-26.
34. Doksum KA, Normand SLT. Gaussian models for degradation processes - Part I: methods for the analysis of biomarker data. Lifetime Data Analysis 1995; 1: 131-44.
35. Herman SM. Perturbation of normal random vectors by nonnormal translations, and an application to HIV latency time distributions. The Annals of Applied Probability 1994; 4: 968-80.
36. Doksum KA. Degradation models for failure time and survival data. CWI Quarterly 1991; 4: 199-205.
37. Hamilton JD, Hartigan PM, Simberkoff MS et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. New England Journal of Medicine 1992; 326: 437-43.
38. O'Brien WA, Hartigan PM, Martin D et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New England Journal of Medicine 1996; 334: 426-31.
39. Zimmerman DL, Nuñez-Anton V. Structured antedependence models for longitudinal data. Technical report 253, University of Iowa, September 1996.